{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:25:46Z","timestamp":1778675146064,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.coviro.2015.04.007","type":"journal-article","created":{"date-parts":[[2015,5,23]],"date-time":"2015-05-23T03:16:19Z","timestamp":1432350979000},"page":"61-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models"],"prefix":"10.1016","volume":"13","author":[{"given":"William W","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajvir","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujan","family":"Shresta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2015.04.007_bib0280","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","article-title":"Dengue","volume":"370","author":"Halstead","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2015.04.007_sbref0285","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2015.04.007_bib0290","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2015.04.007_bib0295","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2015.04.007_bib0300","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2014","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.coviro.2015.04.007_bib0305","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1179\/2046904712Z.00000000046","article-title":"Dengue: an escalating public health problem in Latin America","volume":"32","author":"Tapia-Conyer","year":"2012","journal-title":"Paediatr Int Child Health"},{"key":"10.1016\/j.coviro.2015.04.007_bib0310","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4269\/ajtmh.2006.74.449","article-title":"Serotype-specific differences in clinical manifestations of dengue","volume":"74","author":"Balmaseda","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coviro.2015.04.007_bib0315","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1136\/bmj.324.7353.1563","article-title":"Dengue: an escalating problem","volume":"324","author":"Gibbons","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.coviro.2015.04.007_bib0320","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1473-3099(09)70254-3","article-title":"Progress towards a dengue vaccine","volume":"9","author":"Webster","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coviro.2015.04.007_bib0325","series-title":"Number of Reported Cases of Dengue and Severe Dengue (SD) in the Americas, by Country\u2014January 05, 2015 (EW 51)","author":"PAHO\/WHO","year":"2014"},{"key":"10.1016\/j.coviro.2015.04.007_bib0330","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/265739a0","article-title":"Antibody-enhanced dengue virus infection in primate leukocytes","volume":"265","author":"Halstead","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2015.04.007_bib0335","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri3014","article-title":"Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms","volume":"11","author":"Rothman","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coviro.2015.04.007_bib0340","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nm887","article-title":"Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever","volume":"9","author":"Mongkolsapaya","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2015.04.007_bib0345","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4269\/ajtmh.2002.66.765","article-title":"Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever","volume":"66","author":"Messer","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coviro.2015.04.007_bib0350","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/viro.1997.8504","article-title":"Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas","volume":"230","author":"Rico-Hesse","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2015.04.007_bib0355","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1128\/JVI.79.2.853-859.2005","article-title":"Selection for virulent dengue viruses occurs in humans and mosquitoes","volume":"79","author":"Cologna","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.04.007_bib0360","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1086\/517587","article-title":"Dengue virus evolution and virulence models","volume":"44","author":"Rico-Hesse","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2015.04.007_bib0365","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0140-6736(99)04015-5","article-title":"Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever","volume":"354","author":"Watts","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2015.04.007_bib0370","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.antiviral.2008.06.010","article-title":"Mouse models of dengue virus infection and disease","volume":"80","author":"Yauch","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2015.04.007_bib0375","doi-asserted-by":"crossref","first-page":"e1002934","DOI":"10.1371\/journal.ppat.1002934","article-title":"DENV inhibits type I IFN production in infected cells by cleaving human STING","volume":"8","author":"Aguirre","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.04.007_bib0380","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.chom.2010.10.007","article-title":"Mouse STAT2 restricts early dengue virus replication","volume":"8","author":"Ashour","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2015.04.007_bib0385","doi-asserted-by":"crossref","first-page":"e1002780","DOI":"10.1371\/journal.ppat.1002780","article-title":"Dengue virus targets the adaptor protein MITA to subvert host innate immunity","volume":"8","author":"Yu","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.04.007_bib0390","doi-asserted-by":"crossref","first-page":"e1000790","DOI":"10.1371\/journal.ppat.1000790","article-title":"Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification","volume":"6","author":"Balsitis","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.04.007_bib0395","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.1128\/JVI.00062-06","article-title":"Murine model for dengue virus-induced lethal disease with increased vascular permeability","volume":"80","author":"Shresta","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.04.007_bib0400","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.chom.2010.01.004","article-title":"Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease","volume":"7","author":"Zellweger","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2015.04.007_bib0405","doi-asserted-by":"crossref","first-page":"8276","DOI":"10.1128\/JVI.00365-09","article-title":"Cardif-mediated signaling controls the initial innate response to dengue virus in vivo","volume":"83","author":"Perry","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.04.007_bib0410","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1099\/vir.0.045088-0","article-title":"Characterization of a model of lethal dengue virus 2 infection in C57BL\/6 mice deficient in the alpha\/beta interferon receptor","volume":"93","author":"Orozco","year":"2012","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2015.04.007_bib0415","doi-asserted-by":"crossref","first-page":"e54220","DOI":"10.1371\/journal.pone.0054220","article-title":"Tracking the evolution of dengue virus strains D2S10 and D2S20 by 454 pyrosequencing","volume":"8","author":"Makhluf","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2015.04.007_sbref0420","doi-asserted-by":"crossref","first-page":"11383","DOI":"10.1128\/JVI.01108-14","article-title":"Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection","volume":"88","author":"Weiskopf","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.04.007_bib0425","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.4049\/jimmunol.1101970","article-title":"Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design","volume":"187","author":"Weiskopf","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2015.04.007_bib0430","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.1128\/JVI.03827-13","article-title":"Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines","volume":"88","author":"Zust","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.04.007_bib0435","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1084\/jem.20101158","article-title":"Type I interferon is selectively required by dendritic cells for immune rejection of tumors","volume":"208","author":"Diamond","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2015.04.007_bib0440","doi-asserted-by":"crossref","first-page":"12138","DOI":"10.1128\/JVI.00375-12","article-title":"Trafficking and replication patterns reveal splenic macrophages as major targets of dengue virus in mice","volume":"86","author":"Prestwood","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.04.007_bib0445","doi-asserted-by":"crossref","first-page":"e1004541","DOI":"10.1371\/journal.ppat.1004541","article-title":"Monocyte recruitment to the dermis and differentiation to dendritic cells increases the targets for dengue virus replication","volume":"10","author":"Schmid","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.04.007_bib0450","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity","volume":"8","author":"Beltramello","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2015.04.007_bib0455","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nri891","article-title":"Antibodies, viruses and vaccines","volume":"2","author":"Burton","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coviro.2015.04.007_bib0460","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1017\/S1462399408000665","article-title":"Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection","volume":"10","author":"Pierson","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.coviro.2015.04.007_bib0465","doi-asserted-by":"crossref","first-page":"e1004386","DOI":"10.1371\/journal.ppat.1004386","article-title":"Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera","volume":"10","author":"de Alwis","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.04.007_bib0470","doi-asserted-by":"crossref","first-page":"e00873","DOI":"10.1128\/mBio.00873-13","article-title":"The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein","volume":"4","author":"Smith","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2015.04.007_bib0475","doi-asserted-by":"crossref","first-page":"e1003157","DOI":"10.1371\/journal.ppat.1003157","article-title":"Therapeutic efficacy of antibodies lacking Fcgamma receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies","volume":"9","author":"Williams","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.04.007_bib0480","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1128\/JVI.01087-10","article-title":"Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2","volume":"84","author":"Sukupolvi-Petty","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.04.007_bib0485","doi-asserted-by":"crossref","first-page":"e1000823","DOI":"10.1371\/journal.ppat.1000823","article-title":"The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1","volume":"6","author":"Shrestha","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.04.007_bib0490","doi-asserted-by":"crossref","first-page":"e1004031","DOI":"10.1371\/journal.ppat.1004031","article-title":"First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies","volume":"10","author":"Ng","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.04.007_sbref0495","doi-asserted-by":"crossref","first-page":"e1003723","DOI":"10.1371\/journal.ppat.1003723","article-title":"Role of humoral versus cellular responses induced by a protective dengue vaccine candidate","volume":"9","author":"Zellweger","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.04.007_bib0500","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/JVI.73.1.783-786.1999","article-title":"New mouse model for dengue virus vaccine testing","volume":"73","author":"Johnson","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.04.007_bib0505","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.4049\/jimmunol.175.4.2676","article-title":"Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes","volume":"175","author":"Mangada","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2015.04.007_bib0510","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.4049\/jimmunol.176.6.3821","article-title":"T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?","volume":"176","author":"Mongkolsapaya","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2015.04.007_bib0515","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev-immunol-031210-101315","article-title":"Immune response to dengue virus and prospects for a vaccine","volume":"29","author":"Murphy","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coviro.2015.04.007_bib0520","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.4049\/jimmunol.0801974","article-title":"A protective role for dengue virus-specific CD8+ T cells","volume":"182","author":"Yauch","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2015.04.007_bib0525","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.4049\/jimmunol.1001709","article-title":"CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination","volume":"185","author":"Yauch","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2015.04.007_bib0530","doi-asserted-by":"crossref","first-page":"12561","DOI":"10.1128\/JVI.06743-11","article-title":"Gamma interferon (IFN-gamma) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-alpha\/beta receptor-deficient mice","volume":"86","author":"Prestwood","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.04.007_sbref0535","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.4049\/jimmunol.1401597","article-title":"CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice","volume":"193","author":"Zellweger","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2015.04.007_bib0540","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4049\/jimmunol.1102124","article-title":"Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells","volume":"188","author":"Zompi","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2015.04.007_sbref0545","doi-asserted-by":"crossref","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells","volume":"110","author":"Weiskopf","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.04.007_bib0550","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1128\/JVI.79.9.5665-5675.2005","article-title":"Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections","volume":"79","author":"Simmons","year":"2005","journal-title":"J Virol"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625715000577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625715000577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T10:49:26Z","timestamp":1599043766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625715000577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":55,"alternative-id":["S1879625715000577"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2015.04.007","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2015.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}